Skip to main content

Market Overview

Today's Morning Top Gainers (M,CHIP,BSDM,FTBK,NCT)

Share:

VeriChip Corporation (NASDAQ: CHIP) is among the top percentage gainers in morning trade and surged among 32% today to $3.70 on huge volume of 8.43 million shares. Yesterday, the stock surged over 135% after VeriChip and its development partner RECEPTORS LLC, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the H1N1 virus.

Macy's, Inc. (NYSE: M) rallied 6% on 5 million shares and now trades at $18.85 after Citigroup Inc. upgraded the second-biggest U.S. department store company to “buy” from “hold,” citing expectations for increasing revenue.

BSD Medical Corporation (NASDAQ: BSDM) is also moving higher by 134% to $4.40 on 3.73 million shares after it reported today that the U.S. Food and Drug Administration (FDA) continues its review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company's BSD-2000 Hyperthermia System.

Frontier Financial Corporation (NASDAQ: FTBK) soared 50% now trades at $1.77 on an unusual volume of 11.68 million shares on no news. In the last 5 trading sessions the stock has jumped up over 127%.

Newcastle Investment Corp. (NYSE: NCT) jumped up 17% to $3.76 on massive volume of 780K shares on no news. In the last 5 trading sessions the stock has jumped up over 138%.

 

Related Articles (BSDM + CHIP)

View Comments and Join the Discussion!

Posted-In: Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com